Loss of p16 expression is a sensitive marker of CDKN2A homozygous deletion in malignant meningiomas

IF 9.3 1区医学 Q1 CLINICAL NEUROLOGY

Acta Neuropathologica Pub Date : 2023-02-01 DOI:10.1007/s00401-023-02544-6

Vivian Tang, Rufei Lu, Kanish Mirchia, Jessica Van Ziffle, Patrick Devine, Julieann Lee, Joanna J. Phillips, Arie Perry, David R. Raleigh, Calixto-Hope G. Lucas, David A. Solomon

引用次数: 5

Abstract Image

查看原文本刊更多论文

p16表达缺失是恶性脑膜瘤中CDKN2A纯合缺失的敏感标志

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Acta Neuropathologica 医学-病理学

CiteScore

23.70

自引率

3.90%

发文量

118

审稿时长

4-8 weeks

期刊介绍： Acta Neuropathologica publishes top-quality papers on the pathology of neurological diseases and experimental studies on molecular and cellular mechanisms using in vitro and in vivo models, ideally validated by analysis of human tissues. The journal accepts Original Papers, Review Articles, Case Reports, and Scientific Correspondence (Letters). Manuscripts must adhere to ethical standards, including review by appropriate ethics committees for human studies and compliance with principles of laboratory animal care for animal experiments. Failure to comply may result in rejection of the manuscript, and authors are responsible for ensuring accuracy and adherence to these requirements.